J&J files COVID-19 vaccine application with U.S. FDA

Feb 4 (Reuters) - Johnson & Johnson JNJ.N said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for emergency use.

The drugmaker's application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report in which it said the vaccine had a 66% rate of preventing infections in its large global trial. nL1N2K406P

(Reporting by Vishwadha Chander in Bengaluru; Editing by Caroline Humer and Matthew Lewis)

((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132;))